THERAFLU FLU & CHEST CONGESTION HOT LIQUID OTC
Generic Name and Formulations:
Acetaminophen 1000mg, guaifenesin 400mg; pwd packets; natural citrus flavor; contains sodium 15mg, potassium 5mg, phenylalanine 24mg per packet.
Novartis Consumer Health
Indications for THERAFLU FLU & CHEST CONGESTION HOT LIQUID:
Minor aches and pains. Fever. Headache. Sore throat. Cough. Chest congestion.
Dissolve contents of 1 packet in 8oz of hot water; sip while hot. Consume entire drink within 10–15 minutes. Take every 6 hours; max 4 packets/24hrs.
Concomitant other acetaminophen products.
Hepatic dysfunction. COPD. Asthma. Discontinue if symptoms worsen or persist after 2–7 days. Pregnancy. Nursing mothers.
Analgesic + expectorant.
Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds